These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17106327)

  • 1. Estrogen-progestogen replacement therapy and ovarian cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Dec; 15(6):490-2. PubMed ID: 17106327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and ovarian cancer risk: a meta-analysis.
    Zhou B; Sun Q; Cong R; Gu H; Tang N; Yang L; Wang B
    Gynecol Oncol; 2008 Mar; 108(3):641-51. PubMed ID: 18221779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of hormone use to cancer risk.
    Bernstein L; Ross RK; Henderson BE
    J Natl Cancer Inst Monogr; 1992; (12):137-47. PubMed ID: 1616798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study.
    Weber AM
    Obstet Gynecol; 1997 Oct; 90(4 Pt 1):641-2. PubMed ID: 9380334
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and gynecological cancer.
    Gadducci A; Fanucchi A; Cosio S; Genazzani AR
    Anticancer Res; 1997; 17(5B):3793-8. PubMed ID: 9427782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone therapies and ovarian cancer].
    Grenman S; Salmi T
    Duodecim; 2002; 118(4):349-56. PubMed ID: 12233039
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal replacement therapy in menopause and cancer risk. An update].
    La Vecchia C; Franceschi S
    Minerva Ginecol; 2003 Jun; 55(3):217-9. PubMed ID: 14581867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and combined hormone therapy for women after genital malignancies: a review.
    Levgur M
    J Reprod Med; 2004 Oct; 49(10):837-48. PubMed ID: 15568410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
    Greiser CM; Greiser EM; Dören M
    Hum Reprod Update; 2005; 11(6):561-73. PubMed ID: 16150812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():409-10. PubMed ID: 12448047
    [No Abstract]   [Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and breast cancer: what is the problem?
    Kenemans P
    Maturitas; 2005 May; 51(1):75-82. PubMed ID: 15883112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and ovarian cancer risk--any news?
    Riman T
    Acta Obstet Gynecol Scand; 2007; 86(9):1032-4. PubMed ID: 17712640
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of mammographic density in evaluating changes in breast cancer risk.
    Pike MC
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():1-5. PubMed ID: 16112948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy use and the risk of stroke.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.